Brister Mark 4
4 · OBALON THERAPEUTICS INC · Filed Jan 4, 2019
Insider Transaction Report
Form 4
Brister Mark
VP of Research and Development
Transactions
- Award
Stock Option (Right to Buy)
2019-01-02+100,000→ 100,000 totalExercise: $2.30Exp: 2029-01-02→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date.